Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

Local control

  • You have access
    Clinical Prognostic Factors for Local Control and Survival After Irradiation of Grade II Gliomas
    JASPAR WITTELER, STEVEN E. SCHILD and DIRK RADES
    In Vivo November 2020, 34 (6) 3719-3722; DOI: https://doi.org/10.21873/invivo.12220
  • You have access
    Proton Therapy for Primary Renal Cell Carcinoma: The First Nationwide Retrospective Study in Japan
    NOBUYOSHI FUKUMITSU, HITOSHI ISHIKAWA, TAKESHI ARIMURA, HITOSHI WADA, TOMOAKI OKIMOTO, YOSHITAKA SATO, HIROMITSU IWATA, SHOSEI SHIMIZU and HIDEYUKI SAKURAI
    In Vivo September 2020, 34 (5) 2883-2889; DOI: https://doi.org/10.21873/invivo.12116
  • You have access
    Using Image-guided Intensity-modulated Radiotherapy on Patients With Head and Neck Soft-tissue Sarcoma
    KHALED ELSAYAD, DENISE STOCKMANN, MOHAMMED CHANNAOUI, SERGIU SCOBIOALA, ANETA GRAJDA, HENDRIK BERSSENBRÜGGE, SEBASTIAN HUSS, CHRISTOS MOUSTAKIS, UWE HAVERKAMP, JOHANNES KLEINHEINZ, GEORG LENZ, EVA WARDELMANN and HANS THEODOR EICH
    In Vivo July 2019, 33 (4) 1293-1300; DOI: https://doi.org/10.21873/invivo.11602
  • You have access
    The Importance of Concurrent Chemotherapy for T1 Esophageal Cancer: Role of FDG-PET/CT for Local Control
    ICHIRO OGINO, SHIGENOBU WATANABE, KINGO HIRASAWA, TOSHIHORO MISUMI, MASAHARU HATA and CHIKARA KUNISAKI
    In Vivo September 2018, 32 (5) 1269-1274; DOI: https://doi.org/10.21873/invivo.11376
  • You have access
    Early PET-CT After Stereotactic Radiotherapy for Stage 1 Non-small Cell Lung Carcinoma Is Predictive of Local Control
    MARGUERITE TYRAN, NATHALIE CHARRIER, JULIEN DARREON, ANNE MADROSZYK, AGNES TALLET and NAJI SALEM
    In Vivo January 2018, 32 (1) 121-124;
  • You have access
    Outcomes After Radio(chemo)therapy for Non-Metastatic Bile Duct Cancer
    LOUISA BOLM, LUKAS KAESMANN, TOBIAS BARTSCHT, STEVEN E. SCHILD and DIRK RADES
    In Vivo January 2017, 31 (1) 117-120;
  • You have access
    Clinical Factors Associated with Treatment Outcomes Following Whole-brain Irradiation in Patients with Prostate Cancer
    LIESA DZIGGEL, STEVEN E. SCHILD, THEO VENINGA, AMIRA BAJROVIC and DIRK RADES
    In Vivo January 2017, 31 (1) 35-38;
  • You have access
    Stereotactic Body Radiotherapy Provides Excellent Long-Term Local Control of Very Few Lung Metastases
    STEFAN JANSSEN, LUKAS KÄSMANN, VOLKER RUDAT and DIRK RADES
    In Vivo March 2016, 30 (2) 155-157;
In Vivo

© 2023 In Vivo

Powered by HighWire